Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
Medtronic
AstraZeneca
McKinsey

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Telotristat ethyl


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Telotristat ethyl?

Telotristat ethyl is an investigational drug.

There have been 15 clinical trials for Telotristat ethyl. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2020.

The most common disease conditions in clinical trials are Neuroendocrine Tumors, Serotonin Syndrome, and Carcinoid Tumor. The leading clinical trial sponsors are Lexicon Pharmaceuticals, TerSera Therapeutics LLC, and Ipsen.

There are thirteen US patents protecting this investigational drug and one hundred and twenty-three international patents.

Recent Clinical Trials for Telotristat ethyl
TitleSponsorPhase
Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine TumorM.D. Anderson Cancer CenterPhase 3
Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylTerSera Therapeutics LLCPhase 2
Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylBig Ten Cancer Research ConsortiumPhase 2

See all Telotristat ethyl clinical trials

Clinical Trial Summary for Telotristat ethyl

Top disease conditions for Telotristat ethyl
Top clinical trial sponsors for Telotristat ethyl

See all Telotristat ethyl clinical trials

US Patents for Telotristat ethyl

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Telotristat ethyl ⤷  Try it Free Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase ACTELION PHARMACEUTICALS LTD (Allschwil, CH) ⤷  Try it Free
Telotristat ethyl ⤷  Try it Free Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (Berlin, DE) FORSCHUNGSVERBUND BERLIN E.V. (Berlin, DE) ⤷  Try it Free
Telotristat ethyl ⤷  Try it Free 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) ⤷  Try it Free
Telotristat ethyl ⤷  Try it Free 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) ⤷  Try it Free
Telotristat ethyl ⤷  Try it Free Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) ⤷  Try it Free
Telotristat ethyl ⤷  Try it Free 1-phenyl-1H-pyrazole-based compounds Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Telotristat ethyl

Drugname Country Document Number Estimated Expiration Related US Patent
Telotristat ethyl Canada CA2927121 2033-11-19 ⤷  Try it Free
Telotristat ethyl China CN105745211 2033-11-19 ⤷  Try it Free
Telotristat ethyl European Patent Office EP3071567 2033-11-19 ⤷  Try it Free
Telotristat ethyl Spain ES2650921 2033-11-19 ⤷  Try it Free
Telotristat ethyl Japan JP2016537378 2033-11-19 ⤷  Try it Free
Telotristat ethyl Japan JP6561055 2033-11-19 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
Medtronic
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.